Haijie Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Haijie Wang has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
Baolin Kan
Hainan Key Laboratory for Sustainable Utilization of Tropical Bioresource, Institute of Tropical Crops, Hainan University, Haikou, 570228, China
1 shared publicationCaiguang Liu
Department of Gastroenterology The First Affiliated Hospital of Sun Yat‐Sen University Guangzhou China
1 shared publicationCanhui Sun
Department of Radiology The First Affiliated Hospital of Sun Yat‐sen University Guangzhou China
1 shared publicationChenglong Wang
Shanghai Key Laboratory of Magnetic Resonance East China Normal University Shanghai China
1 shared publication- Chuhuai Wang
Department of Rehabilitation Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China
1 shared publication Guang Yang
Shanghai Key Laboratory of Magnetic Resonance East China Normal University Shanghai China
1 shared publication
Latest Publications
- Open Access
- 3 April 2026
- Published by Wiley in Interdisciplinary Medicine
- Vol. 4 (4)
Multimodal MRI and multiomics reveal high‐risk neurophenotype in brain‐gut circuits as therapeutic target for Crohn's disease
The brain‐gut axis shapes Crohn's disease (CD) pathogenesis, yet CD‐associated neurophenotypes lack defined clinical and mechanistic significance. This work aimed to define these neurophenotypes, assess their prognostic impact, elucidate neurophenotype‐driven progression mechanisms using multi‐omics, and validate their therapeutic potential in vivo. 109 CD patients were prospectively recruited from two centers and underwent baseline multimodal neuro‐MRI, MR enterography, ileocolonoscopy, and fecal/blood sample collection. The neurophenotypes were characterized using a multimodal neuro‐MRI model developed from 13 of 13,870 features. 83 patients were followed up for disease progression, with repeated brain‐gut assessments. Multi‐omics (fecal microbiome/metabolomics, serum metabolomics/neurotransmitters) were used to decode the mechanisms underlying neurophenotype‐driven progression. Dextran sulfate sodium (DSS)‐induced colitis mice with different neurophenotypes were treated with repeated transcranial magnetic stimulation (rTMS) to explore its therapeutic potential. Multimodal neuro‐MRI accurately mapped CD‐specific neural signatures, stratifying patients into high‐risk (neurophenotype score ≥ 0.45) and low‐risk neurophenotypes with robust cross‐center validity (training cohort AUC = 0.842, test cohort AUC = 0.824). High‐risk neurophenotype was identified as an independent predictor of accelerated disease progression (Hazard ratio = 15.46, p = 0.030), independent of intestinal inflammation. Integrated multi‐omics revealed that the high‐risk neurophenotype contributed to CD progression through microbial‐metabolic‐neurotransmitter networks where tryptophan emerged as the central regulatory hub. Serum tryptophan levels were negatively correlated with neurophenotype severity and intestinal disease progression. rTMS targeting high‐risk neurophenotype in DSS‐induced colitis mice elevated tryptophan levels and ameliorated intestinal disease activity. This study redefines the high‐risk neurophenotype as a sustained pathogenic driver rather than a mere phenomenon, proposing brain‐gut axis modulation as a promising therapeutic strategy distinct from conventional anti‐inflammatory approaches.
- 3 April 2026
- Published by Wiley in Interdisciplinary Medicine
- Vol. 4 (4)
Open AccessMultimodal MRI and multiomics reveal high‐risk neurophenotype in brain‐gut circuits as therapeutic target for Crohn's disease
The brain‐gut axis shapes Crohn's disease (CD) pathogenesis, yet CD‐associated neurophenotypes lack defined clinical and mechanistic significance. This work aimed to define these neurophenotypes, assess their prognostic impact, elucidate neurophenotype‐driven progression mechanisms using multi‐omics, and validate their therapeutic potential in vivo. 109 CD patients were prospectively recruited from two centers and underwent baseline multimodal neuro‐MRI, MR enterography, ileocolonoscopy, and fecal/blood sample collection. The neurophenotypes were characterized using a multimodal neuro‐MRI model developed from 13 of 13,870 features. 83 patients were followed up for disease progression, with repeated brain‐gut assessments. Multi‐omics (fecal microbiome/metabolomics, serum metabolomics/neurotransmitters) were used to decode the mechanisms underlying neurophenotype‐driven progression. Dextran sulfate sodium (DSS)‐induced colitis mice with different neurophenotypes were treated with repeated transcranial magnetic stimulation (rTMS) to explore its therapeutic potential. Multimodal neuro‐MRI accurately mapped CD‐specific neural signatures, stratifying patients into high‐risk (neurophenotype score ≥ 0.45) and low‐risk neurophenotypes with robust cross‐center validity (training cohort AUC = 0.842, test cohort AUC = 0.824). High‐risk neurophenotype was identified as an independent predictor of accelerated disease progression (Hazard ratio = 15.46, p = 0.030), independent of intestinal inflammation. Integrated multi‐omics revealed that the high‐risk neurophenotype contributed to CD progression through microbial‐metabolic‐neurotransmitter networks where tryptophan emerged as the central regulatory hub. Serum tryptophan levels were negatively correlated with neurophenotype severity and intestinal disease progression. rTMS targeting high‐risk neurophenotype in DSS‐induced colitis mice elevated tryptophan levels and ameliorated intestinal disease activity. This study redefines the high‐risk neurophenotype as a sustained pathogenic driver rather than a mere phenomenon, proposing brain‐gut axis modulation as a promising therapeutic strategy distinct from conventional anti‐inflammatory approaches.
- 13 May 2023
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 59 (2) , 483-493
A Deep Learning Pipeline Using Prior Knowledge for Automatic Evaluation of Placenta Accreta Spectrum Disorders With MRI
Background: The diagnosis of prenatal placenta accreta spectrum (PAS) with magnetic resonance imaging (MRI) is highly dependent on radiologists' experience. A deep learning (DL) method using the prior knowledge that PAS‐related signs are generally found along the utero‐placental borderline (UPB) may help radiologists, especially those with less experience, to mitigate this issue.Purpose: To develop a DL tool for antenatal diagnosis of PAS using T2‐weighted MR images.Study Type: Retrospective.Subjects: Five hundred and forty pregnant women with clinically suspected PAS disorders from two institutions, divided into training (409), internal test (103), and external test (28) datasets.Field Strength/Sequence: Sagittal T2‐weighted fast spin echo sequence at 1.5 T and 3 T.Assessment: An nnU‐Net was trained for placenta segmentation. The UPB straightening approach was used to extract the utero‐placental boundary region. The UPB image was then fed into DenseNet‐PAS for PAS diagnosis. DenseNet‐PP learnt placental position information to improve the PAS diagnosis performance. Three radiologists with 8, 10, and 12 years of experience independently evaluated the images. Two radiologists marked the placenta tissue. Histopathological findings were the reference standard.Statistical Tests: Area under the curve (AUC) was used to evaluate the classification. Dice coefficient evaluated the segmentation between radiologists and the model performance. The Mann–Whitney U‐test or the chi‐squared test assessed the significance of differences. Decision curve analysis was used to determine clinical effectiveness. DeLong's test was used to compare AUCs.Results: Of the 540 patients, 170 had PAS disorders confirmed by histopathology. The DL model using UPB images and placental position yielded the highest AUC of 0.860 and 0.897 in internal test and external test cohorts, respectively, significantly exceeding the performance of three radiologists (internal test AUC, 0.737–0.770).Data Conclusion: By extracting the UPB image, this fully automatic DL pipeline achieved high accuracy and may assist radiologists in PAS diagnosis using MRI.Level of Evidence: 3Technical Efficacy: Stage 2
- 13 May 2023
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 59 (2) , 483-493
A Deep Learning Pipeline Using Prior Knowledge for Automatic Evaluation of Placenta Accreta Spectrum Disorders With MRI
Background: The diagnosis of prenatal placenta accreta spectrum (PAS) with magnetic resonance imaging (MRI) is highly dependent on radiologists' experience. A deep learning (DL) method using the prior knowledge that PAS‐related signs are generally found along the utero‐placental borderline (UPB) may help radiologists, especially those with less experience, to mitigate this issue.Purpose: To develop a DL tool for antenatal diagnosis of PAS using T2‐weighted MR images.Study Type: Retrospective.Subjects: Five hundred and forty pregnant women with clinically suspected PAS disorders from two institutions, divided into training (409), internal test (103), and external test (28) datasets.Field Strength/Sequence: Sagittal T2‐weighted fast spin echo sequence at 1.5 T and 3 T.Assessment: An nnU‐Net was trained for placenta segmentation. The UPB straightening approach was used to extract the utero‐placental boundary region. The UPB image was then fed into DenseNet‐PAS for PAS diagnosis. DenseNet‐PP learnt placental position information to improve the PAS diagnosis performance. Three radiologists with 8, 10, and 12 years of experience independently evaluated the images. Two radiologists marked the placenta tissue. Histopathological findings were the reference standard.Statistical Tests: Area under the curve (AUC) was used to evaluate the classification. Dice coefficient evaluated the segmentation between radiologists and the model performance. The Mann–Whitney U‐test or the chi‐squared test assessed the significance of differences. Decision curve analysis was used to determine clinical effectiveness. DeLong's test was used to compare AUCs.Results: Of the 540 patients, 170 had PAS disorders confirmed by histopathology. The DL model using UPB images and placental position yielded the highest AUC of 0.860 and 0.897 in internal test and external test cohorts, respectively, significantly exceeding the performance of three radiologists (internal test AUC, 0.737–0.770).Data Conclusion: By extracting the UPB image, this fully automatic DL pipeline achieved high accuracy and may assist radiologists in PAS diagnosis using MRI.Level of Evidence: 3Technical Efficacy: Stage 2
- Open Access
- 29 July 2019
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 1-10
Characterization of genes in guar gum biosynthesis based on quantitative RNA-sequencing in guar bean (Cyamopsis tetragonoloba)
Guar gum is an important raw material in the food, textile and oil industries, but the biosynthesis of guar gum remains unclear. To illuminate the genes involved in guar gum biosynthesis, guar beans from 30 and 40 days after flowering (DAF) were used for RNA sequencing in this study. A total of 2,535 and 2,724 preferentially expressed genes were found in 30 and 40 DAF endosperm, and 3,720 and 2,530 preferentially expressed genes were found in 30 and 40 DAF embryos, respectively. Of these, mannan synthase genes, α-galactosyltransferase genes and cellulose synthase genes were preferentially expressed in the endosperm from 30 and 40 DAF. The high expression level of these glycometabolism genes in endosperm is consistent with the expectation that the main component of guar gum is galactomannan. We believe that genes related to guar gum biosynthesis found in this study will be useful for both new variety development via genetic engineering and synthetic biology research on guar gum biosynthesis in the future.
- 29 July 2019
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 1-10
Open AccessCharacterization of genes in guar gum biosynthesis based on quantitative RNA-sequencing in guar bean (Cyamopsis tetragonoloba)
Guar gum is an important raw material in the food, textile and oil industries, but the biosynthesis of guar gum remains unclear. To illuminate the genes involved in guar gum biosynthesis, guar beans from 30 and 40 days after flowering (DAF) were used for RNA sequencing in this study. A total of 2,535 and 2,724 preferentially expressed genes were found in 30 and 40 DAF endosperm, and 3,720 and 2,530 preferentially expressed genes were found in 30 and 40 DAF embryos, respectively. Of these, mannan synthase genes, α-galactosyltransferase genes and cellulose synthase genes were preferentially expressed in the endosperm from 30 and 40 DAF. The high expression level of these glycometabolism genes in endosperm is consistent with the expectation that the main component of guar gum is galactomannan. We believe that genes related to guar gum biosynthesis found in this study will be useful for both new variety development via genetic engineering and synthetic biology research on guar gum biosynthesis in the future.